Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies

ClinicalTrials.gov ID: NCT03467152

Public ClinicalTrials.gov record NCT03467152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will be conducted to compare Irsenontrine to placebo on the cognitive endpoint of Montreal Cognitive Assessment (MoCA) and the global clinical endpoint of Clinician's Interview Based Impression of Change Plus (CIBIC-Plus) Caregiver Input in participants with dementia with Lewy bodies after 12 weeks of treatment.

Study identification

NCT ID
NCT03467152
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
326 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 3, 2018
Primary completion
Apr 14, 2020
Completion
Apr 14, 2020
Last update posted
Jul 31, 2022

2018 – 2020

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Banner Sun Health Research Institute Sun City Arizona 85351
Advanced Research Center Inc Anaheim California 92805
Parkinsons and Movement Disorders Institute Fountain Valley California 92708
Paradigm Clinical Research Centers, Inc San Diego California 92117
Syrentis Clinical Research Santa Ana California 92705
New England Institute for Clinical Research Stamford Connecticut 06905
Miami Jewish Health-Clinical Research Miami Florida 33137
Elias Research Associates (Allied Biomedical Research Institute) Miami Florida 33155
Pharmax Research of South Florida; Elias Research Associates Miami Florida 33175
Compass Research-Bioclinica Orlando Florida 32806
Neurology Associates of Ormond Beach Ormond Beach Florida 32174
Advanced Research Consultants, Inc. Palm Beach Gardens Florida 33410
Anchor Neuroscience Pensacola Florida 32502
Compass Research-Bioclinica The Villages Florida 32162
Indiana University, Dept of Neurology Indianapolis Indiana 46202
University of Kentucky, Dept of Neurology Sanders Brown Center on Aging Lexington Kentucky 40504
University of Michigan Ann Arbor Michigan 48106
Neurological Associates of Albany, PC Albany New York 12208
Columbia University New York New York 10032
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103
Cleveland Clinic, Lou Ruvo Center for Brain Health at Lakewood Hospital Lakewood Ohio 44107
Summit Research Network (Oregon) Inc. Portland Oregon 97210
New Orleans Center for Clinical Research Knoxville Tennessee 37920
Kerwin Research Center, LLC Dallas Texas 75231-4350
University of Virginia Adult Neurology Charlottesville Virginia 22903

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03467152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2022 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03467152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →